Reduced TRPC Channel Expression in Psoriatic Keratinocytes Is Associated with Impaired Differentiation and Enhanced Proliferation by Leuner, Kristina et al.
Reduced TRPC Channel Expression in Psoriatic










3, Christoph M. Schempp
2, Walter E. Mu ¨ller
1
1Institute of Pharmacology, Biocenter Niederursel, Johann Wolfgang Goethe-University, Frankfurt, Germany, 2Department of Dermatology, University Medical Center,
Freiburg, Germany, 3Department of Dermatology, Johann Wolfgang Goethe-University, Frankfurt, Germany, 4Institute of Pharmacology and Toxicology & Interfaculty
Centre for Pharmacogenomics and Drug Research, Eberhard-Karls-University, Tu ¨bingen, Germany
Abstract
Psoriasis is a characteristic inflammatory and scaly skin condition with typical histopathological features including increased
proliferation and hampered differentiation of keratinocytes. The activation of innate and adaptive inflammatory cellular
immune responses is considered to be the main trigger factor of the epidermal changes in psoriatic skin. However, the
molecular players that are involved in enhanced proliferation and impaired differentiation of psoriatic keratinocytes are only
partly understood. One important factor that regulates differentiation on the cellular level is Ca
2+. In normal epidermis, a
Ca
2+ gradient exists that is disturbed in psoriatic plaques, favoring impaired keratinocyte proliferation. Several TRPC
channels such as TRPC1, TRPC4, or TRPC6 are key proteins in the regulation of high [Ca
2+]ex induced differentiation. Here, we
investigated if TRPC channel function is impaired in psoriasis using calcium imaging, RT-PCR, western blot analysis and
immunohistochemical staining of skin biopsies. We demonstrated substantial defects in Ca
2+ influx in psoriatic keratinocytes
in response to high extracellular Ca
2+ levels, associated with a downregulation of all TRPC channels investigated, including
TRPC6 channels. As TRPC6 channel activation can partially overcome this Ca
2+ entry defect, specific TRPC channel activators
may be potential new drug candidates for the topical treatment of psoriasis.
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Introduction
Psoriasis is a common chronic immune skin disease that affects
more than 25 million people in North America and Europe [1]. It
has a multifactorial etiology including cellular, genomic and
genetic alterations, leading to microscopic and macroscopic
disease-specific skin alterations, including inflammation, leukocyte
infiltration and enhanced keratinocyte proliferation. Psoriatic
lesions are characterized by thickened, irregular stratum corneum
with parakeratosis and epidermal thickening with acanthosis and
papillomatosis and absence of the granular layer. Thickening of
the epidermis is a consequence of strongly increased keratinocyte
proliferation, accompanied by reduced keratinocyte differentia-
tion, eventually leading to reduced skin barrier function. These
specific skin alterations are considered to be mainly the
consequence of the inflammatory process and not a primary event
in the pathophysiology [1,2,3]. The molecular mediators and
intracellular signalling cascades of the inflammatory process
involving T lymphocytes, dendritic cells and macrophages are
well characterized [4]. However, the mediators which are
responsible for enhanced proliferation and impaired differentia-
tion of psoriatic keratinocytes are not identified yet. Proinflamma-
tory cytokines such as IFN-c, TGF-ß, IL-6 or IL-8 have no effect
or even inhibit keratinocyte proliferation [5,6]. The contribution
of IL-20 and IL-22, cytokines produced by keratinocytes and T
cells, to altered differentiation in psoriatic keratinocytes is currently
discussed [7,8]. However, a primary defect within the cellular
mechanisms regulating keratinocyte maturation is also conceivable
[9].
A first hint was reported nearly 20 years ago by Menon and
Elias who described a defect of the epidermal calcium gradient in
psoriatic skin [10]. In normal skin, extracellular Ca
2+ ([Ca
2+]ex)
increases substantially from the basal over the spinous to the
granular layer of the epidermis. As the calcium gradient is thought
to represent an important physiological mechanism regulating
keratinocyte maturation, defects in this system could easily explain
altered proliferation and differentiation of psoriatic keratinocytes.
However, the findings of Menon and Elias have so far not been
reproduced by others.
Similar to the Ca
2+ gradient in the epidermis, the differentiation
and proliferation of isolated keratinocytes in vitro is regulated by an
increase in intracellular Ca
2+ ([Ca
2+]i) via both Ca
2+ release from
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2+ influx mechanisms. High extracellu-
lar Ca
2+ concentrations ([Ca
2+]ex) activate the Ca
2+ sensing
receptor (CaR), a G-protein-coupled receptor [11]. This leads to
the stimulation of the phospholipase C (PLC) pathway, generating
inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) [12]. IP3
as ligand of IP3 receptors induces release of Ca
2+ from the
endoplasmic reticulum (ER) and consecutive Ca
2+ influx known as
‘‘store operated calcium influx’’ (SOCE). DAG directly activates
members of the canonical transient receptor potential (TRPC)
channel family and contributes to receptor operated calcium influx
(ROC). Among the superfamily of TRP channels, TRPC channels
have been suggested to be involved in SOCE, ROC and to play a
key role in cell differentiation [13,14].
TRPC channels can be divided into the TRPC1, TRPC4 and
TRPC5 group and the TRPC3, TRPC6 and TRPC7 group,
whereof DAG directly activates only the latter ones [15]. TRPC1
and TRPC4 seem to be involved in SOCE in keratinocytes,
whereas TRPC6 and TRPC7 play an important role in ROC
mediated Ca
2+ influx [16,17,18,19]. Furthermore, several TRPC
channels are considered to be relevant for keratinocyte differen-
tiation. TRPC1, TRPC4, as well as TRPC7 and TRPC6 have
been implicated in the CaR triggered elevation of [Ca
2+]i and
differentiation [20,21,19]. Importantly, we could show that
specific activation of TRPC6 with hyperforin [22,18] is sufficient
to induce full differentiation and to inhibit proliferation similar to
high [Ca
2+]ex. In addition, TRPC1, TRPC5, TRPC6 and TRPC7
are upregulated after Ca
2+-induced differentiation of gingival
keratinocytes [21]. TRPC channels might also be involved in skin
diseases such as Darier’s disease [23] or actinic keratoses [24].
Therefore, we decided to test whether changes in [Ca
2+]i
homeostasis including the CaR, the release of Ca
2+ from the ER or
TRPC channels are present in isolated psoriatic keratinocytes and
are involved in the observed deficiencies in keratinocyte
differentiation. We investigated primary keratinocytes isolated
from psoriatic plaques with Ca
2+ imaging, western blot analysis,
RT-PCR and skin biopsies from psoriasis patients with immuno-
histochemical staining. We demonstrated substantial defects in
Ca
2+ influx in psoriatic keratinocytes in response to high
extracellular Ca
2+ levels, associated with a downregulation of all
TRPC channels which are involved in ROC and SOCE, including
TRPC6 channels which play a crucial role in keratinocyte
differentiation. As TRPC6 channel activation could partially
overcome this Ca
2+ entry defect in psoriasis keratinocytes, specific
TRPC6 channel activators e.g. out of the phloroglucinol class may
be potential new drug candidates for the topical treatment of
psoriasis.
Results
Impaired calcium homeostasis in psoriatic keratinocytes
To investigate if calcium homeostasis is impaired in psoriasis
keratinocytes, we mimicked the steep calcium gradient in the skin
using high [Ca
2+]ex (2 mM) and compared the increase in [Ca
2+]i
of psoriatic keratinocytes and hpK. The resulting Ca
2+ influx was
strongly reduced in psoriatic keratinocytes (Fig. 1 A, B). We then
asked if this defect is caused by the primary target of high [Ca
2+]ex,
the CaR, or consecutive players such as the release of Ca
2+ from
the ER or TRPC channels which are important in CaR mediated
calcium influx. First experiments were conducted using thapsi-
gargin in the presence and absence of [Ca
2+]ex. Thapsigargin is an
inhibitor of the endoplasmic reticulum (ER)-Ca
2+ ATPase and was
used to empty Ca
2+ stores from ER [25]. The addition of
thapsigargin (100 mM) in Ca
2+-free medium raised slightly the
[Ca
2+]i in both keratinocyte types (Fig. 1 E, F). Under these
conditions, the increase of [Ca
2+]i is solely due to depletion of
internal stores. No significant difference between the rise in [Ca
2+]i
of psoriatic keratinocytes and hpK was observed.
In contrary to the results in Ca
2+-free environment, in Ca
2+-
containing medium thapsigargin mobilizes not only a release from
internal stores, but also a Ca
2+-influx across the plasma membrane
via store operated calcium channels (Fig. 1C, 1D). In fact, addition
of thapsigargin (100 mM) in Ca
2+-containing medium strongly
increased the [Ca
2+]i in psoriatic keratinocytes and hpK (Fig. 1 C,
D). However, the rise in [Ca
2+]i of psoriatic keratinocytes was
significantly lower than the increase of [Ca
2+]i in hpK (Fig. 1D).
This finding would be compatible with defects at the levels of ion
channels mediating the store operated calcium influx such as
TRPC1 or TRPC4 channels.
To test if TRPC channels, as downstream targets of CaR, might
also be involved in impaired Ca
2+ influx, the TRPC6 activator
hyperforin [22,18] was used to induce a pronounced Ca
2+ influx.
In psoriatic keratinocytes, [Ca
2+]i (Fig. 1G) was significantly
decreased after hyperforin addition (Fig. 1H). These findings
suggest that the CaR and/or TRPC channels might be involved in
the defects in calcium entry in psoriatic keratinocytes. Importantly,
basal Ca
2+ levels were not different between psoriatric keratino-
cytes (79.1611.2 nM) and hpK (61.268.8 nM).
The CaR expression is reduced in lesional psoriatic
keratinocytes
We investigated a possible role of CaR in the altered Ca
2+
response to high [Ca
2+]ex by analyzing CaR mRNA levels in
psoriatic keratinocytes isolated from 6 patients in comparison to 6
different hpK (Data S1). Keratinocytes from psoriatic lesions
showed a slightly reduced expression of the receptor (20%)
suggesting that reduced expression of CaR is not the major cause
of the decreased Ca
2+ influx in psoriatic keratinocytes. Further-
more, thapsigargin mediated Ca
2+ influx does not differ between
psoriatic keratinocytes and hpK. Therefore, we decided to further
investigate the downstream targets of the signalling cascade, the
TRPC channels.
Involvement of TRPC channels in defects of psoriatic
keratinocytes
To evaluate if the decreased receptor operated Ca
2+ influx in
psoriatic keratinocytes is caused by reduced expression levels of
TRPC channels, we first performed RT-PCR analysis in
keratinocytes isolated from psoriatic lesional skin (Fig. 2 A, B).
As shown in Fig. 3 A, the mRNA levels of all members of the
TRPC subfamily were significantly reduced in psoriatic keratino-
cytes compared to hpK. To investigate if TRPC channel protein
levels are also down regulated in psoriatic skin, we obtained
stratum corneum from psoriatic plaques of 6 patients and
compared it to stratum corneum from 6 healthy controls. Western
blot analysis of the plaques was performed to analyze the
expression of TRPC channels (Fig. 2 C). The protein levels of
the channels appear to be reduced in psoriatic plaques in
comparison with proteins extracted out of stratum corneum from
6 volunteers. However, a correct quantification of the TRP protein
bands was not possible because of the widening of the protein
bands obtained for the psoriatic samples. This widending is
suprising and currently not understood, it might be a reflection of
degradation.
In addition, we performed immunohistochemical stainings on
punch biopsies obtained from five lesional and five non lesional
psoriasis skin samples compared to five healthy controls (Fig. 3).
Firstly, the biopsies from untreated psoriasis lesions, non lesional
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the expression of the nuclear proliferation marker protein Ki67
that is expressed in cells undergoing the S/G2/M transition. Ki67
is a well established marker to detect proliferating cells [26]. As
shown in Fig. 3 protein expression of Ki67 is strongly increased in
lesional psoriasis epidermis and moderately increased in non
lesional psoriasis skin, demonstrating the hyperproliferative
condition of psoriatic keratinocytes. Secondly, we analyzed the
expression of the late differentiation marker filaggrin. Filaggrin
was only expressed in a patchy fashion in psoriasis lesions, whereas
it formed a continuous layer at the transition from the stratum
granulosum to stratum corneum in both non lesional psoriatic and
normal skin (Fig. 3). Similarly the early differentiation marker K10
was analyzed. Compared to non lesional psoriatic skin and normal
skin the number of K10 expressing keratinocyte layers was
considerably lower in lesional psoriasis epidermis (Fig. 3),
indicative of disturbed keratinocyte differentiation in psoriasis as
it has already been demonstrated in several reports (for a
comprehensive review please see Tschachler et al., 2007).
To explore if abnormalities in TRPC expression can also be
demonstrated in non-lesional and lesional skin obtained from
psoriasis patients using immunohistochemistry, we analyzed
exemplary the expression of the TRPC1-, TRPC4- and
TRPC6-channels which are known to be important players in
CaR induced Ca
2+ influx (Cai et al. 2006; Fatherazi et al., 2007;
Mu ¨ller et al., 2008). TRPC1 was mainly expressed in stratum
basale of the epidermis in skin biopsies from healthy controls and,
to a somewhat lesser extent in lesional and lesional psoriatic skin
(Fig. 3). Similarly, the stainings for TRPC4 and TRPC6 were also
weaker in psoriasis lesions (Fig. 3). The staining characteristics are
summarized in Table 1.
Taken together, our findings using RT-PCR, western blotting
and immunohistochemistry strongly suggest down-regulated
expression of TRPC channels in psoriasis on the mRNA and
protein level.
Disturbed differentiation and proliferation in psoriatic
keratinocytes
Consequently, we asked if the decreased receptor operated
calcium influx caused by decreased TRPC channel expression
results in disturbed differentiation and proliferation of psoriatic
keratinocytes. RT-PCR analyses revealed that hPK cells express
basal levels of K10 and TGM1 which are up-regulated during
high [Ca
2+] treatment (Fig. 4A, C). K10 and TGM1 both are
markers for keratinocyte differentiation. K10 and TGM1 levels
were increased in psoriatic keratinocytes incubated with high
[Ca
2+]ex-containing medium (Fig. 4A, C), but to a much lower
extent compared to hpK. This is also supported by the slightly
reduced expression levels of both markers under baseline
conditions (legend to Fig. 4). Our findings are compatible with
the assumption of an impaired balance between differentiation
and proliferation in psoriatic keratinocytes. Incubation of psoriasis
keratinocytes and hpK with a high [Ca
2+]ex resulted in a reduced
cell proliferation in both cell types. However, compared to hpK
the anti-proliferative effect of high [Ca
2+]ex was significantly lower
in psoriatic keratinocytes (Fig. 4 E).
In summary, these findings demonstrate that psoriatic kerati-
nocytes display a disturbed balance between differentiation and
proliferation, presumably due to a defect of the epidermal calcium
homeostasis that is associated with a reduced expression of TRPC
channels.
TRPC6 activation partly restores the disturbed
differentiation and proliferation in psoriatic keratinocytes
To investigate if increased TRPC channel function restores the
abnormalities observed in psoriasis keratinocytes, the effect of the
TRPC6 activator hyperforin (1 mM) on the expression of the
differentiation markers K10 and TGM1 and on cell proliferation
was investigated. Hyperforin significantly increased the expression
of the early differentiation marker K10 and the late differentiation
marker TGM1 in both psoriatic keratinocytes and hpK (Fig. 4 B,
D). Even more important, hyperforin reduced the proliferation of
hpK and psoriatic keratinocytes to similar extent (Fig. 4 F). While
the inhibition of proliferation by hyperforin appears to be slightly
higher than the effect of high [Ca
2+]ex, its effects on the expression
of the differentiation markers are rather similar. Taken together,
these findings suggest that TRPC channel activation might be a
promising treatment strategy to overcome the disturbed matura-
tion of keratinocytes in psoriasis.
Discussion
Intracellular calcium measurements, expression analysis and
immunohistological staining allowed us to unravel the defects of
psoriatic keratinocytes differentiation and the potential molecular
elicitors. This study describes findings from in vitro a well as ex vivo
analyses to clarify the pathomechanisms of keratinocyte dysfunc-
tion in psoriatic skin. Our data show that the impaired calcium
homeostasis in psoriatic keratinocytes leading to defects in
differentiation and proliferation is associated with downregulated
expression of CaR and TRPC channels. Consequently, in calcium
imaging experiments, psoriatic keratinocytes showed a reduced
calcium influx after stimulation with high [Ca
2+]ex. TRPC1,
TRPC4, TRPC7 and TRPC6 have been implicated in the
calcium-induced differentiation in vitro [21] although TRPC6
seems to play a substantial role, as its stimulation by its activator
hyperforin is sufficient to induce a full differentiation response
[18]. In agreement with the important role of TRPC6, the Ca
2+
influx mediated by the TRPC6 activator hyperforin was
significantly impaired in psoriatic keratinocytes. A reduced
[Ca
2+]i in psoriasis keratinocytes has also been reported by
Karvonen et al. (2000) following stimulation with thapsigargin,
which has been explained by reduced Ca
2+ release from the ER
[27]. However, these experiments were conducted in the presence
of high [Ca
2+]ex. We were able to reproduce and to extend these
findings indicating the primary role of defects in Ca
2+ entry
mechanisms such as SOCE as well as ROC.
As our results implicated a defect in CaR and/or TRPC
channels, we examined the expression pattern of CaR and TRPC
Figure 1. High [Ca
2+]ex-, thapsigargin, and hyperforin-induced changes in [Ca
2+]i in psoriatic keratinocytes. Psoriatic keratinocytes and
hpK were loaded with fura-2 and stimulated with high [Ca
2+]ex 2 mM, thapsigargin 100 mM, and hyperforin 10 mM( A, B). Representative time traces
and mean changes in fura-2 ratio from high [Ca
2+]ex-induced (2 mM) changes in [Ca
2+]i in psoriatic keratinocytes to hpK. Representative time traces
show thapsigargin-induced elevation of [Ca
2+]i in calcium-containing buffer (C), and calcium-free buffer (E). Thapsigargin was added 50 s after the
start of the experiment. D and F, the mean Ca
2+-elevation in psoriatic keratinocytes compared to hpK after the stimulation with thapsigargin in
buffer containing 1 mM Ca
2+,o rC a
2+-free buffer. G and H, hyperforin-induced calcium influx in psoriatic keratinocytes and hpK. Asterisks denote
statistical significance as compared to hpK (psoriatic keratinocytes n=6, 2 Ca
2+ measurements per stimuli/patient; hpK n=6, 2–4 Ca
2+ measurements
per stimuli/control;, *P,0.05, **P,0,01, ***P,0.001, ns=non significant unpaired t test).
doi:10.1371/journal.pone.0014716.g001
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e14716Figure 2. Reduced TRPC channel expression in psoriatic keratinocytes. A, mRNA expression of all TRPC channels in psoriatic keratinocytes
and hpK was determined using RT-PCR analyses. B, Histogram reflecting relative expressing levels of the channels, compared to their normalized
expression levels in hpK. TRPC levels of psoriasis patients were first normalized on their internal 18S control and then compared to hpK. Asterisks
denote statistical significance as compared to control keratinocytes (n=6, **P,0,01, ***P,0.001 unpaired t test). C, Western blotting of TRPC
channels in protein samples taken stratum corneum from 6 psoriasis patients in comparison with stratum corneum obtained from 6 healthy
volunteers. The protein levels have been normalized to GAPDH expression. Representative blots from single experiment that were repeated three
times are shown.
doi:10.1371/journal.pone.0014716.g002
TRPC Channels in Psoriasis
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e14716TRPC Channels in Psoriasis
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e14716channels in cultured psoriatic keratinocytes compared to control
human keratinocytes. By RT-PCR a slightly reduced expression of
CaR could be detected which however seems to be too small to
solely explain the pronounced changes in [Ca
2+]i. In addition, the
expression levels of all TRPC channels on mRNA and protein
levels are significantly reduced both in cultured psoriatic
keratinocytes and psoriasis plaques, as we could detect with RT-
PCR and western blot analysis. Our findings of a diminished
TRPC1-, TRPC4- and TRPC6-channel expression were con-
firmed by immunohistological stainings of punch biopsies from
psoriasis plaques. This approach already demonstrated a down-
regulation of TRPC channels in non lesional skin which is even
more pronounced in lesional skin from the same patient and
healthy controls. This provides a more plausible explanation for
the link between defects in calcium homeostasis and disturbed
differentiation of psoriatic keratinocytes. Up to now, only external
elicitors like a loss of the calcium gradient, abnormal barrier
function or enhanced production of the cytokines IL-20 or IL-22
in T cells (and consecutively in keratinocytes) have been
hypothesized to play a role in the altered differentiation and
proliferation in psoriatic skin [10,4]. Our findings show for the first
time that a specific defect of calcium influx regulating mechanisms
represent a major intrinsic feature of psoriasis keratinocytes,
eventually leading to pronounced alterations in differentiation and
proliferation. Importantly, changes in TRPC channel expression
and defects in calcium signalling were also present in cultured
psoriasis keratinocytes detached from their in vivo environment
which is in agreement with many other studies (see the
comprehensive review by Tschachler) [28]. Using a similar
preparation, Wu et al. 2009 investigated the expression of
filaggrin-2 in lesional and non-lesional skin from psoriasis patients
and found only reduced expression in lesional skin [29].
Therefore, acute inflammatory processes and cytokines released
by T cells cannot sufficiently explain the observed changes in
calcium signalling. However, we cannot answer the question if
decreased TRPC channel expression is acquired by inflammatory
processes or if an intrinsic defect together with cytokines released
from infiltrating T cells, contributes to keratinocyte alterations,
resulting in acanthosis, hyperkeratosis and parakeratosis in vivo.
Karvonen et al. (2000) postulated an inherited defect in calcium
metabolism because the altered Ca
2+ influx after store depletion
was still present up to the fifth passage of cultured psoriatic
keratinocytes and could be also detected in keratinocytes isolated
from non lesional skin. These assumptions are supported by the
findings that keratinocytes isolated from lesional and nonlesional
skin equally appear to be ‘‘diseased’’ and that additional stressors
such as cytokines can trigger the formation of psoriatic plaques
[30,8,4,7].
The hypothesis that TRPC channels might be a novel target for
the treatment of psoriasis is supported by our findings that specific
TRPC6 activation by hyperforin not only elevates [Ca
2+]i but also
at least partially overcomes the intrinsic defect of maturation.
Hyperforin increased keratinocyte differentiation as indicated by
the enhanced expression of the differentiation markers K10 and
Table 1. Characteristics of psoriasis patients (Pso) and control subjects (Con) and semiquantiative enumeration of
immunohistological stainings.
Sample Age Sex Localization Ki67* Filaggrin** KRT10*** TRPC1**** TRPC4**** TRPC6****
Pso 1 lesional 67 F Thigh 35/7 (+)3 + (focally ++) + (+)
Pso 2 lesional 49 F Forearm 28/7 (+)3 ++ (focally 2) + (diffuse)
Pso 3 lesional 40 M Hip 24/5 (+)2 + (diffuse) + (+)
Pso 4 lesional 26 M Forearm 28/8 (+)4 ++ (focally 2) +
Pso 5 lesional 57 F Thigh 32/12 2 5 ++ 2
Pso 1 non lesional 67 F Thigh 11/9 + 2 + (basal ++) + (+)
Pso 2 non lesional 49 F Forearm 15/6 + 2 ++ ++ (+)
Pso 3 non lesional 40 M Hip 9/5 + 2 + (basal ++) ++ (+)
Pso 4 non lesional 26 M Forearm 11/9 + 1 ++ ++ (+)
Pso 5 non lesional 57 F Thigh 15/8 + 2 ++ (+)
Con 1 79 F Back 4/2 + 2 ++ (basal +++) ++ +
Con 2 74 F Abdomen 10/4 + 2 + (basal ++) ++ +
Con 3 63 M Thigh 5/4 + 1 ++ +++ +
Con 4 33 F Thigh 6/3 + 1 ++ ++ (+)
Con 5 67 M Thigh 2/1 + 2 ++ (basal +++) ++ +
F, female; M, male.
*Ki67: number of positive cells/HPF (mean/SD).
**Filaggrin: staining intensity (2 negative; (+) fragmentary; + continuous band in the upper epidermis).
***KRT10: number of unstained basal layers.
****TRPC1, TRPC4, TRPC6: staining intensity (2 negative; (+) weak; + slightly positive; ++ marked positive; +++ strongly positive).
doi:10.1371/journal.pone.0014716.t001
Figure 3. TRPC channel protein expression is reduced in immunohistochemical stainings of psoriatic lesional skin. Lesional and
adjacent non lesional skin from psoriasis patients (n=5) and skin from healthy controls (n=6) were stained on the same slide for the expression of
Ki67, filaggrin, KRT10, TRPC1, TRPC4 and TRPC6 using the LSAB method as described in the methods section. Isotype matched non-specific primary
antibodies were used as negative controls. A, Histological scans showing staining patterns of the whole epidermis. Shown are representative sections
(bar, 200 mm). B, Histological scans with a higher magnification showing more details of the celllular TRPC staining (bar, 10 mm).
doi:10.1371/journal.pone.0014716.g003
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to restore the defect completely to hpK control levels. Further-
more, hyperforin decreased proliferation in psoriasis keratinocytes
and hpK to similar extent which might be another pathophysio-
logically important aspect. Furthermore, TRPC channels are
discussed to be involved in Darier’s disease and atopic dermatitis
[23,24]. However, therapeutical effectiveness of targeting TRPC
channel function and expression as a potential therapeutical
concept for psoriasis will require much more data. While
hyperforin itself might be less useful due to its chemical instability,
our findings that TRPC6 activation can be mimicked by rather
simple phloroglucinol derivatives opens a further possibility to
investigate this approach [31].
Taken together, our data shows for the first time that TRPC
channels are involved in the pathogenesis of psoriasis and that they
might be a promising new target for the treatment of psoriasis.
Figure 4. High [Ca
2+]ex and hyperforin-induced differentiation and proliferation of psoriatic keratinocytes. Psoriatic keratinocytes and
hpK were incubated for 48 h with Ca
2+ (2 mM, A, C) or hyperforin (1 mM, B, D). Total mRNA of treated cells was isolated, reverse transcribed and
subjected to PCR. The expression of the differentiation markers K10 (A, B) and TGM I (C, D) were analyzed. Histograms are showing relative
expression levels of the differentiation markers compared to their normalized expression levels in untreated controls. The baseline expression levels
of TGM and K10 (normalized for the respective GAPDH expression) were somewhat different between patients and controls in these experiments
carred out in the presence of [Ca
2+]ex 0.1 mM. TGM: hpK 0.5460.13, PSO 0.3860.19 (p=0.11), K10 hpK 0.4060.11, PSO 0.2860.08 (p=0.06). Asterisks
denote statistical significance as compared to control keratinocytes (n=5/6, *P,0.05, **P,0.01, ***P,0.001 unpaired t test). E and F, proliferation
was detected using a BrdU immunoassay kit. Cells were incubated 48 h with Ca
2+ (2 mM, E) or hyperforin (1 mM, F). Relative changes in percentage in
the absorbance at 450 nm compared to the untreated control were measured (n=6,*P,0.05, **P,0.01, ***P,0.001, unpaired t test).
doi:10.1371/journal.pone.0014716.g004
TRPC Channels in Psoriasis
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Sources and preparation of reagents
Hyperforin was a kind gift of Dr. Willmar Schwabe, Karlsruhe
(Germany). Fluorescence dye fura-2-AM was purchased from
Molecular Probes (Eugene, OR, U.S.A).
Patients and skin samples
To obtain psoriatic keratinocytes, punch biopsies from typical
psoriatic plaques of six patients were taken after written informed
consent and the protocol was approved by the ethics committee of
the University of Frankfurt, Germany. Skin biopsies for immuno-
histochemistry were from untreated psoriasis lesions and adjacent
non lesional skin (n=5) and from normal skin obtained from
dermatological surgery (n=5). All patients gave their written
informed consent to use their skin in the study and the protocol
was approved by the ethics committee of the University of
Freiburg, Germany. The biopsies were fixed in paraformaldehyde,
embedded in paraffin and stored at room temperature until
immunohistochemical analysis.
Cell culture
To isolate psoriatic keratinocytes, punch biopsies from typical
psoriatic plaques of six patients were taken. Normal primary
keratinocytes (hpK) were derived from adult skin obtained from
dermatological surgery. Both types of keratinocytes were cultured
according to the method of Rheinwald and Green [32] in
keratinocyte growth medium (Promo Cell, Heidelberg, Germany)
under a 5% CO2 humidified atmosphere at 37uC.
For cell culture experiments, keratinocytes were seeded in 6-well
plates for RT-PCR and western blot, and on glass cover slips for
Ca
2+ imaging. For differentiation studies, cells were allowed to
attach for 24 hours after trypsinization; subsequently 0.1 mM
Ca
2+-containing keratinocyte-SFM medium (Invitrogen) with 10%
heat-inactivated fetal calf serum (Sigma-Aldrich). Afterwards,
medium was replaced by SFM medium without fetal calf serum
with 2 mM Ca
2+ or 1 mM hyperforin. After 48 h incubation in the
latter medium RT-PCR of corresponding markers was performed.
Immunohistochemistry
3 mm sections of paraffin-embedded lesional and adjacent non
lesional skin from psoriasis patients (n=5) and skin from healthy
controls (n=5) were stained for Ki67, filaggrin, KRT10, TRPC1,
TRPC4 and TRPC6 using the LSAB method (DCS, Hamburg,
Germany) as described by [24]. The biopsies were stained with a
specific antibody on the same slide. Isotype matched non-specific
primary antibodies were used as negative controls.The following
antibodies and dilutions were used: the primary polyclonal
TRPC6 antibody (Chemicon, Schwalbach Germany), 1:200; the
polyclonal TRPC4 antibody (Santa Cruz Biotechnology, Inc.,
Heidelberg, Germany), 1:50; the polyclonal TRPC1 antibody
(Santa Cruz Biotechnology, Inc., Heidelberg, Germany), 1:500;
the polyclonal filaggrin antibody (Santa Cruz Biotechnology, Inc.,
Heidelberg, Germany), 1:5000; the monoclonal KRT10 antibody
(Santa Cruz Biotechnology, Inc., Heidelberg, Germany), 1:1000;
the polyclonal Ki-67 antibody (DCS, Hamburg, Germany), 1:200;
The matched isotype controls were rabbit IgG (Dako, Glostrup,
Denmark, 1:500), goat IgG (Dianova, 1:200) and mouse IgG
(Dako, 1:1000). The secondary antibody multi-link-biotin, the
streptavidin-HRP-label and the AEC-substrate were from Dako
and were used according to the manufacturer’s instruction.
Stainings with isotype matched non specific primary antibodies
served as control and were negative in all cases.
RT-PCR
RNA was isolated using TRIzol reagent (Invitrogen, Karlsruhe,
Germany), chloroform, and 100% ethanol according to manufac-
turer’s instructions. Reactions were carried out using 2 mgo f
mRNA. First-strand cDNA was synthesized from 2 mg total RNA
in 20 ml final volume using a First Strand cDNA Synthesis Kit
(Invitrogen, Karlsruhe, Germany). After reverse transcription,
amplification was carried out by PCR using the Taq DNA
polymerase and dNTP Set of Invitrogen. A 2 ml aliquot of the
reverse transcription solution was used as a template for specific
PCR. The PCR primers used to amplify TRPC1, 3, 4, 5, 6 and 7
channels, TGM1, K10 and CaR cDNAs are specified in Table 2.
Commercially available 18S rRNA primers (Ambion, Huntington,
UK) were used as internal loading control and the predicted 18S
(Classic II) band size was 324 bp. The PCR was conducted under
the following conditions: an initial denaturation step at a
temperature of 94uC for 5 min and 30 cycles as follows: 30 s at
94uC, 30 sec at 58uC, 30 sec at 72uC, and finally 7 min at 72uC.
PCR products were run on a 1% agarose gel and stained with
ethidium bromide. Changes in relative mRNA levels were
obtained by relating each PCR product to its internal control.
After gel electrophoresis quantification was archived with
ChemiDoc XRS System and Quantity One Software (Bio-Rad).
Western blotting
Keratinocytes from psoriasis plaques or normal epidermis from
healthy controls were obtained by scratching off stratum corneum
layers from psoriatic plaques or from heel stratum corneum
Table 2.
Name Accession no. Forward (59R39) Backward (59R39) Expected size
K10 NM_00421 GCAAAATCAAGGAGCGGTATGA GAGCTGCACACAGTAGCGACC 685
TGMI NM_000359 GATCGCATCACCCTTGAGTTAC TCCTCATGGTCCACGTACACAAT 304
TRPC1 Z73903 ATGTATACAACCAGCTCTATCTTG AGTCTTTGGTGAGGGAATGATG 525
TRPC3 U47050 CTGCAAATGAGAGCTTTGGC AACTTCCATTCTACATCACTGTC 388
TRPC4 AF175406 ATTCATATACTGCCTTGTGTTG GGTCAGCAATCAGTTGGTAAG 329
TRPC5 AF054568 ACTTCTATTATGAAACCAGAGC GCATGATCGGCAATAAGCTG 289
TRPC6 AF080394 AAGACATCTTCAAGTTCATGGTC TCAGCGTCATCCTCAATTTCC 322
TRPC7 AJ272034 GTCCGAATGCAAGGAAATCT TGGGTTGTATTTGGCACCTC 477
CaR U20760 ATGTGGTAGAGGTGATCCAA GGCGTGGGCAATGGAGTAGA 529
doi:10.1371/journal.pone.0014716.t002
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completeH protease inhibitor cocktail from Roche Diagnostics,
Germany and were used for Western blot experiments. Protein
content was measured according to the Lowry method. Samples
were mixed with Tris/glycine reducing buffer, denaturing loading
buffer (both from Invitrogen
TM, Germany), loaded and electro-
phoresed on NuPAGE
TM 4–12% Bis–Tris Gels (Invitrogen
TM,
Germany). Gels were transferred to PVDF membranes (Amer-
sham Biosciences), incubated overnight with the respective
primary antibodies [TRPC1 (1/200): ACC -010 (Alomone, Israel);
TRPC3 (1/200): ACC-016 (Alomone, Israel); TRPC4 (1/200):
ACC-018 (Santa Cruz Biotechnology, Inc., Heidelberg, Ger-
many); TRPC5 (1:200) ACC-020: (Alomone, Israel); TRPC6 (1/
200): ACC-017 (Alomone, Israel); TRPC7 (1:200): AB9326
(Calbiochem, Germany)] and secondary antibodies (Calbiochem,
Germany) conjugated to horseradish peroxidase and processed for
visualization by ECL
TM Reagent (Amersham Biosciences, Ger-
many). The antibody for Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH, 1/300) (MAB374, Chemicon, Germany) served
as loading control. Relative intensities of the bands were quantified






single cells were carried out using the fluorescence indicator fura-
2-AM in combination with a monochromator-based imaging
system (T.I.L.L. Photonics, Martinsried, Germany or Attofluor
Ratio Vision system) attached to an inverted microscope (Axiovert
100, Carl Zeiss, Oberkochen, Germany). For [Ca
2+]i measure-
ments psoriatic keratinocytes and hpK were loaded with 4 mM
fura-2-AM (Invitrogen) and 0.01% Pluronic F-127 (Invitrogen) for
30 min at room temperature in a standard solution composed of
138 mM NaCl, 6 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5.5 mM
glucose, and 10 mM HEPES (adjusted to pH 7.4 with NaOH).
Cover slips were then washed in this buffer for 20 min and
mounted in a perfusion chamber on the microscope stage. To
measure [Ca
2+]i in Ca
2+-free environment cells were loaded with
fura-2-AM and then washed in Ca
2+-free standard solution. For all
fluorescence experiments, fluorescence was excited at 340 and
380 nm. After correction for background fluorescence, the
fluorescence ratio F340/F380 was calculated.
Proliferation measurement
Quantification of cell proliferation was determined by a non-
isotopic immunoassay kit (Calbiochem, Germany), based on the
measurement of BrdU incorporation during DNA synthesis. The
assay was carried out according to the product instruction manual.
Statistics
In addition to Microsoft Office Excel, GraphPad PRISM
TM
(Version 3.0) was used for statistical analyses and to create the
graphs. For statistical analyses, an unpaired Student’s t-test (two-
tailed) was used. Data are expressed as mean 6 SEM.
Supporting Information
Data S1
Found at: doi:10.1371/journal.pone.0014716.s001 (0.17 MB TIF)
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